Myeloproliferative/lymphoproliferative Neoplasms, Familial (multiple Types), Susceptibility To; Mplpf

Description

Familial myeloproliferative/lymphoproliferative neoplasms is an autosomal dominant cancer predisposition syndrome characterized by adult-onset of hematologic malignancies mainly affecting the myeloid line. Most patients present with myelodysplastic syndrome (MDS ) and/or acute myeloid leukemia (AML ). Rare lymphoid malignancies, including lymphoma, can also occur. Some mutation carriers, even if unaffected by a hematologic malignancy, may have evidence of immune dysregulation disorders, including asthma, eczema, or juvenile arthritis. The disorder shows incomplete penetrance (summary by Lewinsohn et al., 2016). Patients may show a favorable response to treatment with lenalidomide (summary by Polprasert et al., 2015).

Clinical Features

Top most frequent phenotypes and symptoms related to Myeloproliferative/lymphoproliferative Neoplasms, Familial (multiple Types), Susceptibility To; Mplpf

  • Anemia
  • Neoplasm
  • Erythema
  • Arthritis
  • Leukemia
  • Eczema
  • Lymphoma
  • Asthma
  • Leukopenia
  • Bone marrow hypocellularity
And another 8 symptoms. If you need more information about this disease we can help you.
Click here to know more about Mendelian.

Incidence and onset information

Not enough data available about incidence and published cases.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Myeloproliferative/lymphoproliferative Neoplasms, Familial (multiple Types), Susceptibility To; Mplpf Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

BRCA1, BRCA2, VHL, APC, EPCAM, MSH2, PMS2, MSH6, MLH1, MUTYH, PTEN, RUNX1, TP53, SDHAF2, RET, SDHC, FH, SDHB, ANKRD26, TMEM127 , (...)

View the complete list with 34 more genes
Specificity
2 %
Genes
100 %
Hereditary Leukemia and Breast Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

BRCA1, BRCA2, MSH2, PMS2, MSH6, MLH1, PTEN, RUNX1, TP53, ANKRD26, BLM, PTPN11, CBL, ATM, NBN, PALB2, CDH1, CHEK2, GATA2, PAX5 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
100 %
Tier 1: Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL).

By Genetic Services Laboratory University of Chicago in United States.

RUNX1, TP53, ANKRD26, GATA2, PAX5, CEBPA, RTEL1, TERC, TERT, SRP72, IKZF1, ETV6, SAMD9, SAMD9L, DDX41
Specificity
7 %
Genes
100 %
Familial Myeloproliferative/lymphoproliferative Neoplasms.

By Genetic Pathology SA Pathology in Australia.

DDX41
Specificity
100 %
Genes
100 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

BRCA1, BRCA2, HFE, APC, EPCAM, MSH2, PMS2, MSH6, MLH1, MUTYH, PTEN, RECQL4, RUNX1, ABCB11, RB1, SDHAF2, RET, SLC25A13, SDHC, FH , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
100 %
Hereditary Myelodysplastic Syndrome (MDS) /Acute Myeloid Leukemia (AML) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RUNX1, TP53, ANKRD26, GATA2, CEBPA, TERC, TERT, SRP72, ETV6, SAMD9L, DDX41
Specificity
10 %
Genes
100 %
Hereditary Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML) via the DDX41 Gene.

By PreventionGenetics PreventionGenetics in United States.

DDX41
Specificity
100 %
Genes
100 %
DDX41.

By Fulgent Genetics Fulgent Genetics in United States.

DDX41
Specificity
100 %
Genes
100 %
Hereditary Leukemia Panel.

By Blueprint Genetics in Finland.

BRCA1, BRCA2, EPCAM, MSH2, PMS2, MSH6, MLH1, RUNX1, TP53, ANKRD26, BLM, BRAF, HRAS, KRAS, MAP2K1, NRAS, PTPN11, SOS1, TINF2, RIT1 , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
100 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

BRCA1, BRCA2, VHL, APC, EPCAM, MSH2, PMS2, MSH6, MLH1, MUTYH, PTEN, RECQL4, RUNX1, TP53, HNF1A, WT1, SDHAF2, RET, SDHC, RAF1 , (...)

View the complete list with 126 more genes
Specificity
1 %
Genes
100 %
Comprehensive Hematology Panel.

By Blueprint Genetics in Finland.

BRCA1, BRCA2, F2, F5, HFE, EPCAM, MSH2, PMS2, MSH6, MLH1, RECQL4, RUNX1, TP53, YARS2, PC, HBB, TYRP1, OCA2, AMN, SLC45A2 , (...)

View the complete list with 219 more genes
Specificity
1 %
Genes
100 %
Bone Marrow Failure Syndrome Panel.

By Blueprint Genetics in Finland.

BRCA1, BRCA2, EPCAM, MSH2, PMS2, MSH6, MLH1, RECQL4, RUNX1, TP53, SLC37A4, DTNBP1, HPS1, BLOC1S3, HPS6, HPS5, HPS4, HPS3, RPL35A, HAX1 , (...)

View the complete list with 102 more genes
Specificity
1 %
Genes
100 %
Inherited Bone Marrow Failure Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA2, RUNX1, RPL35A, HAX1, FANCC, RPS19, TINF2, PALB2, BRIP1, GATA2, SBDS, CEBPA, RAD51C, MPL, RTEL1, WAS, GATA1, RPS26, RPS10, RPL11 , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
100 %

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL NARCOLEPSY-CATAPLEXY SYNDROME MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61 AICARDI-GOUTIERES SYNDROME 7; AGS7 DYSTONIA 23; DYT23 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24 PREMATURE CHROMATID SEPARATION TRAIT; PCS